UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE TO
(Amendment No. 1)
(Rule 13e-4)
TENDER OFFER STATEMENT PURSUANT TO SECTION 14(D)(1) OR 13(E)(1) OF THE
SECURITIES EXCHANGE ACT OF 1934
________________________________________
StepStone Private Credit Fund LLC
(Name of Subject Company (Issuer))
StepStone Private Credit Fund LLC
(Names of Filing Person (Offeror and Issuer))
Limited Liability Company Interests
(Title of Class of Securities)
________________________________________
None
(CUSIP Number of Class of securities)
Darren Friedman
Chief Executive Officer
StepStone Private Credit Fund LLC
277 Park Avenue, 44th Floor
New York, New York 10172
(212) 351-6100
(Name, address and telephone no. of person authorized to receive notices and communications on behalf of filing person)
________________________________________
Copies to:
Richard Horowitz, Esq.
Clay Douglas, Esq.
Dechert LLP
1095 Avenue of the Americas
New York, NY 10036
(212) 698-3500
________________________________________
☐ | | Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer. |
| | Check the appropriate boxes below to designate any transactions to which the statement relates: |
| | ☐ Third-party tender offer subject to Rule 14d-1. |
| | ☒ Issuer tender offer subject to Rule 13e-4. |
| | ☐ Going-private transaction subject to Rule 13e-3. |
| | ☐ Amendment to Schedule 13D under Rule 13d-2. |
| | Check the following box if the filing is a final amendment reporting the results of the tender offer: ☒ |
FINAL AMENDMENT TO TENDER OFFER STATEMENT
This Amendment No. 1 (this “Amendment”) amends and supplements the Tender Offer Statement on Schedule TO filed by StepStone Private Credit Fund LLC (the “Company”), with the U.S. Securities and Exchange Commission (the “SEC”) on November 1, 2024 (together with any subsequent amendments and supplements thereto, the “Schedule TO”). The Schedule TO relates to the offer by the Company to purchase up to 1,315,366 shares of its outstanding limited liability company interests (the “Shares”), at a purchase price equal to the net asset value per Share as of December 31, 2024, upon the terms and subject to the conditions set forth in the Offer to Purchase, dated November 1, 2024 (together with any amendments or supplements thereto, the “Offer to Purchase”), and in the accompanying Letter of Transmittal (together with any amendments or supplements thereto and with the Offer to Purchase, the “Offer”), which are annexed to and filed with the Schedule TO as Exhibits (a)(1)(ii) and (a)(1)(iii), respectively.
This Amendment is being filed by the Company to report the final results of the Offer. Except as otherwise set forth in this Amendment, the information set forth in the Schedule TO remains unchanged. Capitalized terms used but not defined herein have the meanings ascribed to them in the Schedule TO.
The following information is provided pursuant to Rule 13e-4 under the Securities Exchange Act of 1934, as amended:
• The Company has determined the final results of the Offer, which expired at 11:59 p.m., Eastern Time, on December 2, 2024;
• 67,016.588 Shares were validly tendered and not properly withdrawn prior to the expiration of the Offer. The Company has accepted for purchase 100% of the Shares that were validly tendered and not properly withdrawn prior to the expiration of the Offer, at a purchase price per Share equal to the net asset value per Share as of December 31, 2024;
• The number of Shares that the Company has accepted for purchase in the Offer represents less than 1.0% of the total number of Shares outstanding as of September 30, 2024; and
• On January 30, 2025, the Company determined that, as of December 31, 2024, the net asset value per Share was $26.00 per Share. Based on such net asset value per Share, the aggregate purchase price for the 67,016.588 Shares accepted for purchase by the Company equals approximately $1,742,370.97, which amount will be promptly paid by the Company in cash to the relevant person(s).